Extracellular vesicles promote migration despite BRAF inhibitor treatment in malignant melanoma cells.

Autor: Németh A; Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, Budapest, Hungary., Bányai GL; Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, Budapest, Hungary., Dobos NK; Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, Budapest, Hungary., Kós T; Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, Budapest, Hungary., Gaál A; Institute of Materials and Environmental Chemistry; Biological Nanochemistry Research Group, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary., Varga Z; Institute of Materials and Environmental Chemistry; Biological Nanochemistry Research Group, HUN-REN Research Centre for Natural Sciences, Budapest, Hungary., Buzás EI; Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary.; ELKH-SE Translational Extracellular Vesicle Research Group, Budapest, Hungary.; HCEMM-SE Extracellular Vesicle Research Group, Budapest, Hungary., Khamari D; Department of Genetics, Cell- and Immunobiology, Semmelweis University, Budapest, Hungary., Dank M; Department of Internal Medicine and Oncology, Division of Oncology, Semmelweis University, Budapest, Hungary., Takács I; Department of Internal Medicine and Oncology, Division of Oncology, Semmelweis University, Budapest, Hungary., Szász AM; Department of Internal Medicine and Oncology, Division of Oncology, Semmelweis University, Budapest, Hungary., Garay T; Faculty of Information Technology and Bionics, Pázmány Péter Catholic University, Budapest, Hungary. garay.tamas@itk.ppke.hu.; Department of Internal Medicine and Oncology, Division of Oncology, Semmelweis University, Budapest, Hungary. garay.tamas@itk.ppke.hu.

Publikováno v: Cell communication and signaling : CCS [Cell Commun Signal] 2024 May 22; Vol. 22 (1), pp. 282. Date of Electronic Publication: 2024 May 22.